22 May 2013
Keywords: Roche, Pegasys, Hepatitis C, Children, EMA
Article | 18 March 2013
The European Medicines Agency has expanded the approval of Swiss drug major Roche’s (ROG: SIX) Pegasys (peginterferon alfa-2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 March 2013
21 May 2013
© 2013 thepharmaletter.com